Tag: Coronavirus
New COVID-19 variant JN.1 hits India – What you need to know now
In a startling development, India has reported 21 cases of the new coronavirus variant JN.1, spreading concern across the nation. NITI Aayog member (Health) VK ... Read More
WHO announces JN.1 as variant of interest with low global health risk
The World Health Organization (WHO) made a critical announcement this Tuesday, identifying the JN.1 coronavirus strain as a "variant of interest." This development, while significant, ... Read More
Panic grips the world: Highly transmissible JN.1 Covid variant causes international outbreak
The highly transmissible JN.1 Covid variant is driving a fresh outbreak across more than six countries, leading to the resurgence of social distancing and face ... Read More
COVID-19 crisis deepens in India: New variant JN.1 stirs panic across states
In a dramatic turn of events, Indian authorities issued an urgent advisory on Monday, signaling a state of high alert due to an alarming rise ... Read More
New SARS-CoV-2 variant BA.2.86 detected: UKHSA releases initial risk assessment amid global concerns
The UK Health Security Agency (UKHSA) has unveiled its preliminary risk analysis of the SARS-CoV-2 variant BA.2.86, a strain first detected in the UK on ... Read More
New super-mutant COVID strain emerges: Is this the next global threat?
In a spine-chilling revelation that may alter the trajectory of the global pandemic, the US Centers for Disease Control and Prevention (CDC) announced their surveillance ... Read More
Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India
The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based ... Read More
Visby Medical adds $35m to Series E round for PCR diagnostic technology
Visby Medical, an American medical diagnostic company, has raised an additional $35 million for its PCR diagnostic technology to take its Series E funding round ... Read More
Lilly, US govt sign deal for 600,000 doses of Covid-19 drug bebtelovimab
Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of ... Read More
Novavax reports success for NVX-CoV2373 in pediatric group of phase 3 trial
Novavax said that its Covid-19 vaccine NVX-CoV2373 achieved its primary effectiveness endpoint in the pediatric expansion of its phase 3 PREVENT-19 trial. According to the ... Read More